Studies have (Song et al., 2018; Liu et al., 2020; Zhang et al., 2020) revealed a multicomponent synergistic mechanism and molecular targets of ATR in AD using a system pharmacology strategy. This evidence concerns the gene ATR and Alzheimer disease.